Shake well
The anemia associated with REBETOL therapy may result in a worsening of cardiac disease
For further information on ribavirin dosing and dosage modifications, refer to the ribavirin prescribing information
2) • Should be used in combination with ribavirin for treatment of HCV in adult patients with hepatocellular carcinoma awaiting liver transplantation for up to 48 weeks or until
ribavirin in certain patient populations (see Table 1 )
After oral administration of 600 mg of 14C-ribavirin, approximately 61% and 12%
warning: treatment-related mortality, prolonged severe cytopenia, severe infection, cardiopulmonary and renal impairment COPEGUS (ribavirin) is available as a light pink to pink colored, flat, oval-shaped, film-coated tablet for oral administration
Sovaldi package insert / prescribing information for healthcare professionals
Ribavirin may cause birth defects and fetal death; avoid pregnancy
The safety and efficacy of ribavirin tablets therapy for the treatment of adenovirus, RSV, parainfluenza or influenza infections have not been established
When administered with ZEPATIER , the recommended
For information on ribavirin dosing, refer to the ribavirin prescribing information
The ribavirin (RBV) dosage for adult subjects was weight-based at 1000–1200 mg daily administered in two divided doses when used in combination with SOVALDI, and the peginterferon alfa 2a
2)]
PEGASYS is administered as 180 mcg/1
(peg)interferon, ribavirin and/or sofosbuvir (PRS), treated in the registrational studies excluding EXPEDITION-4 and MAGELLAN-1, the median age was 54 years (range: 19 to
R x only 56 tablets NDC Therefore, ribavirin is contraindicated in patients who are pregnant and in the partners of patients who are pregnant
2
Ribavirin for inhalation has a separate package insert, which should be consulted if ribavirin inhalation therapy is being considered
Ribavirin is a Federal Drug Administration Pregnancy Category X product, indicating that its use is contraindicated in women who are pregnant
Learn about uses, side effects, drug interactions, dosages, warnings, and more
Hepatitis C virus (HCV) infection affects 71 million people worldwide1 and is a leading cause of death globally